Feed-forward inhibition: a novel cellular mechanism for the analgesic effect of substance P
© Wu et al; licensee BioMed Central Ltd. 2005
Received: 29 September 2005
Accepted: 18 November 2005
Published: 18 November 2005
Substance P (SP) is a neuropeptide well known for its contribution to pain transmission in the spinal cord, however, less is known about the possible modulatory effects of SP. A new study by Gu and colleagues, published in Molecular Pain (2005, 1:20), describes its potential role in feed-forward inhibition in lamina V of the dorsal horn of the spinal cord. This inhibition seems to function through a direct excitation of GABAergic interneurons by substance P released from primary afferent fibers and has a distinct temporal phase of action from the well-described glutamate-dependent feed-forward inhibition. It is believed that through this inhibition, substance P can balance nociceptive output from the spinal cord.
The spinal cord dorsal horn is one of the relay stations for nociceptive information transmitted by peripheral sensory afferents. Some of these sensory afferents are substance P (SP) and glutamate-containing Aδ- and C- fibers. Upon noxious stimulation, particularly intense stimulation, tachykinins such as SP and neurokinin A (NKA) are released from primary afferent fibers and excite dorsal horn neurons via activation of the neurokinin-1 and neurokinin-2 receptors (NK1R and NK2R), respectively [1, 2]. A series of studies have established a role for SP in the transmission of pain information [3, 4]. Mice genetically engineered not to express the precursor of SP  and mice that do not express SP's target, the NK1R , both display reduced responses to painful stimuli. Despite these promising initial findings, NK1R antagonists have failed to produce analgesia in a variety of clinical pain models . One possible explanation for these inconsistent results is that SP may produce mixed effects in sensory-related transmission and modulation. Indeed, Mohrland and Gebhart reported that an intrathecal injection of SP had antinociceptive effects . Similarly, a study has found an analgesic effect mediated by SP and further suggested that it might be mediated by μ-2 opioid receptors . Other studies demonstrate an interaction between tachykinin and opioid systems, lending support for a role of opioid receptors in SP-mediated antinociception .
Although many studies have highlighted the importance of SP in pain transmission, the synaptic mechanisms underlying the antinociceptive effect of SP remain unclear. In a recent study published in Molecular Pain, Gu and colleagues used a combination of electrophysiological, pharmacological, genetic and behavioral techniques in rats and found that SP can modulate inhibitory transmission in lamina V of the spinal cord dorsal horn, thereby exerting an analgesic effect on nociceptive sensory processing . Through this finding, the study provides novel insight into the role of SP in the spinal cord dorsal horn, which has important implications for the therapeutic control of pathological pain.
SP drives glutamate-independent feed-forward inhibition
The neuronal network in the spinal dorsal horn is extremely complex. Within this circuit, inhibitory interneurons containing GABA and/or glycine play important roles in controlling network excitability. Activation of these neurons can initiate feedback inhibition and feed-forward inhibition, which are believed to be critical for the fine tuning of sensory information at the spinal level . SP and glutamate, present in some primary afferent fibers that respond to painful stimuli, can mediate excitatory responses in postsynaptic dorsal horn neurons [1, 11]. Although it had been shown that glutamate can bind to receptors on GABA and glycine-releasing interneurons to decrease nociceptive transmission, the possibility that SP could also drive inhibitory activity in the spinal cord dorsal horn had not been explored.
Gu and colleagues stimulated the dorsal root of the spinal cord, which contains primary afferent fibers, with high frequency stimulation to cause the release of both SP and glutamate in the presence of N-methyl-D-aspartate (NMDA) receptors and non-NMDA receptors antagonists. They found a robust and long-lasting increase in both the frequency and amplitude of spontaneous inhibitory postsynaptic currents (sIPSCs). Similar results were obtained with chemical stimulation using capsaicin, which also excites primary afferent fibers to release both glutamate and SP . This increase in sIPSCs when glutamate-mediated excitatory responses were blocked suggests that glutamate-independent feed-forward inhibition exists in the dorsal horn.
Could SP be responsible for glutamate-independent feed-forward inhibition? First, among different neuropeptides such as galanin, neuropeptide Y, somatostatin, calcitonin gene-related peptide and SP tested, only SP enhanced the frequency and amplitude of sIPSCs. These results demonstrate that the effect of SP is selective. Second, application of NK1R antagonists blocked both electrical and chemical stimulation-induced increases of sIPSCs. Third, exogenously applied SP- or stimulation-induced increases of sIPSCs were abolished in NK1R knockout (NK1R-/-) mice. Taken together, these results demonstrate that increases of SP can drive inhibitory activity in the dorsal horn of spinal cord.
To further explore the neuronal mechanisms underlying SP-driven feed-forward inhibition, pharmacological tools were used to show that pertussis toxin-sensitive G proteins such as Gi and Go are involved in SP-driven feed-forward inhibition. Moreover, GIN mice, a strain of transgenic mice that express enhanced green fluorescent protein in GABAergic neurons, were used to show that SP can directly excite some GABAergic neurons by inducing prolonged depolarization, firing of action potentials, and increases of intracellular Ca2+. Since SP had no effect on both miniature inhibitory postsynaptic currents (mIPSC) and evoked inhibitory postsynaptic currents (eIPSC), SP-driven feed-forward inhibition is more likely due to the direct excitation of GABAergic interneurons by SP releasing primary afferent fibers than to action potential-independent modulation of activity within the synapse.
Different temporal phases between SP- and glutamate-driven feed-forward inhibition
Even though SP coexists with glutamate in primary nociceptive afferent synaptic terminals, their roles in various pain conditions may be distinct considering that higher frequencies of primary afferent stimulation are required to evoke the release of SP compared to glutamate . Consistent with this idea, previous electrophysiological studies reported that activation of these fibers produced two phases of excitatory postsynaptic potentials (EPSPs), a fast EPSP mediated by non-NMDA receptors and a slow EPSP possibly mediated by the NK1R and NK2R [1, 14]. Therefore, it is conceivable that SP-driven feed-forward inhibition and glutamate-driven feed-forward inhibition have different temporal phases.
To address this issue, Gu and colleagues first studied SP-driven feed-forward inhibition in the absence of glutamate receptor antagonists . Their results showed that high frequency stimulation induced a robust and long-lasting increase in sIPSCs in wild-type mice but not in NK1R-/- mice. However, electrical stimulation-induced immediate eIPSCs, which could be blocked by glutamate receptor antagonists and are believed to be glutamate-driven feed-forward inhibition, were similar between wild-type and NK1R-/- mice. Taken together, these results provide evidence for a long-lasting, glutamate-independent SP-driven feed-forward inhibition that is distinct from the immediate pulse-by-pulse glutamate-driven feed-forward inhibition.
Functional significance of SP-driven feed-forward inhibition
After confirming the existence of the SP dependent feed-forward inhibition as well as delineating its distinct temporal phase, Gu and colleagues searched for the functional significance of the SP-driven feed-forward inhibition in the spinal cord dorsal horn. They hypothesized that the SP-driven feed-forward inhibition may serve to balance neuronal activity by counteracting SP-mediated excitatory nociceptive responses. This hypothesis challenges the traditional role of SP as a purely "pro-pain" substance in favor of a more homeostatic role.
A clever set of experiments were devised to address this question. First, SP-mediated nociceptive transmission in the superficial dorsal horn was blocked with a selective lesion of NK1R-expressing neurons using an intrathecal injection of SP-conjugated saporin (SP-SAP) [17, 18]. It is important to note that the SP-SAP injection does not cause cytotoxicity in lamina V neurons so the SP-driven feed-forward inhibition remained intact. If an antinociceptive role for SP-driven feed-forward inhibition exists, the activation of SP release would have an analgesic effect in SP-SAP injected animals but blocking SP transmission would result in behavioral sensitization in SP-SAP injected animals.
Behavior responses to nociceptive heat stimuli were studied in SP-SAP treated animals after capsaicin treatment and intrathecal application of NK1R antagonists, resulting in two major findings . First, capsaicin-induced behavioral sensitization in control animals was attenuated in SP-SAP treated animals consistent with the role of SP transmission in the superficial laminae as being "pro-pain". Second, NK1R antagonists reduced behavioral sensitization in the control group whereas the opposite effect was found in SP-SAP treated rats that support a possible antinociceptive role for SP in lamina V, probably through feed-forward inhibition. These results may explain hyperstimulation-induced analgesia, in which pain is controlled through additional painful stimulation or through counter irritation [9, 19], and the lack of an analgesic effect of NK1R antagonists administered in clinical trials . This study portrays SP as a double-edged sword for pain transmission, SP's actions may depend both on the location of release (lamina I vs lamina V) and an the type of neuron it synapses with (projection neurons vs inhibitory neurons).
The elegant study by Gu and colleagues proposes a novel cellular mechanism for the neurokinin system in pain transmission and modulation. Dissecting its intricacies will not only contribute to a better understanding of how somatosensory inputs, including pain information, are coded within the spinal dorsal horn, but may also foster the development of more efficacious treatments for pain control.
Due to the important implications of SP-driven feed-forward inhibition in nociceptive transmission, some limitations of these findings need to be addressed. (1) SP can be released from at least three different sources: primary afferent fibers, descending projections fibers and local neurons. The current study uses dorsal root stimulation so it is likely that the primary afferents are the cause of the SP release [20, 21]. Since it is possible that SP has a different function depending on its source, this study cannot rule out the other potential actions of SP when it is released from local neurons or descending terminals. (2) Activation of the NK1R in lamina V induced interneuronal depolarization and firing that was not due to action potential-independent synaptic transmission. Therefore, these receptors are unlikely to be localized in the presynaptic terminal. It would be interesting to investigate two related issues. One is the exact location of NK1Rs on the neuron, since some studies report that NK1Rs are postsynaptically or extrasynaptically located . The other issue is the molecular mechanism for SP induction of interneuronal excitability. It is thought that SP might directly induce a postsynaptic current or indirectly modulate various receptors and channels. The Gi/Go-coupled NK1R is reported to activate phospholipase A2 and mobilize arachidonic acid . The final targets for the signaling pathway initiated by SP binding to NK1R to result in SP-driven feed-forward inhibition in the spinal cord dorsal horn are still a mystery. (3) Although SP and NKA are synthesized together, they affect spinal nociception in different ways [24, 25]. Still, it cannot be ruled out that NKA might play a role in SP-driven feed-forward inhibition. The study excludes the possible involvement of neurokinin B (NKB) in SP-driven feed-forward inhibition since the NK3R (the receptor for NKB) antagonist did not significantly attenuate capsaicin-induced increases of sIPSCs. (4) This study showed that a long lasting increase in sIPSCs is SP-dependent but glutamate-independent. This conclusion is based on pharmacological studies using ionotropic glutamate receptor antagonists. However, whether metabotropic glutamate receptors are involved in SP-driven inhibition remains unknown. The authors cannot prove without a doubt that SP-driven feed-forward inhibition is glutamate independent without first excluding the potential role of metabotropic glutamate receptors.
Although the complexity of nociceptive transmission and modulation in the spinal cord make it difficult to address all questions in a single model, we believe the description of a SP-driven feed-forward inhibition to be a crucial finding towards the understanding of the role of SP in sensory transmission, modulation and plasticity.
- Li P, Zhuo M: Substance P and neurokinin A mediate sensory synaptic transmission in young rat dorsal horn neurons. Brain Res Bull 2001, 55: 521–531. 10.1016/S0361-9230(01)00553-6PubMedView ArticleGoogle Scholar
- Yoshimura M, Jessell TM: Primary afferent-evoked synaptic responses and slow potential generation in rat substantia gelatinosa neurons in vitro. J Neurophysiol 1989, 62: 96–108.PubMedGoogle Scholar
- De Felipe C, Herrero JF, O'Brien JA, Palmer JA, Doyle CA, Smith AJ, Laird JM, Belmonte C, Cervero F, Hunt SP: Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 1998, 392: 394–397. 10.1038/32904PubMedView ArticleGoogle Scholar
- Cao YQ, Mantyh PW, Carlson EJ, Gillespie AM, Epstein CJ, Basbaum AI: Primary afferent tachykinins are required to experience moderate to intense pain. Nature 1998, 392: 390–394. 10.1038/32897PubMedView ArticleGoogle Scholar
- Rupniak NM, Kramer MS: Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol Sci 1999, 20: 485–490. 10.1016/S0165-6147(99)01396-6PubMedView ArticleGoogle Scholar
- Mohrland JS, Gebhart GF: Substance P-induced analgesia in the rat. Brain Res 1979, 171: 556–559. 10.1016/0006-8993(79)91062-XPubMedView ArticleGoogle Scholar
- Goettl VM, Larson AA: Activity at phencyclidine and mu opioid sites mediates the hyperalgesic and antinociceptive properties of the N-terminus of substance P in a model of visceral pain. Neuroscience 1994, 60: 375–382. 10.1016/0306-4522(94)90251-8PubMedView ArticleGoogle Scholar
- Guan JS, Xu ZZ, Gao H, He SQ, Ma GQ, Sun T, Wang LH, Zhang ZN, Lena I, Kitchen I, Elde R, Zimmer A, He C, Pei G, Bao L, Zhang X: Interaction with vesicle luminal protachykinin regulates surface expression of delta-opioid receptors and opioid analgesia. Cell 2005, 122: 619–631. 10.1016/j.cell.2005.06.010PubMedView ArticleGoogle Scholar
- Nakatsuka T, Chen M, Takeda D, King C, Ling J, Xing H, Ataka T, Vierck C, Yezierski R, Gu JG: Substance P-driven feed-forward inhibitory activity in the mammalian spinal cord. Mol Pain 2005, 1: 20. 10.1186/1744-8069-1-20PubMed CentralPubMedView ArticleGoogle Scholar
- Melzack R, Wall PD: Pain mechanisms: a new theory. Science 1965, 150: 971–979.PubMedView ArticleGoogle Scholar
- De Biasi S, Rustioni A: Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord. Proc Natl Acad Sci U S A 1988, 85: 7820–7824.PubMed CentralPubMedView ArticleGoogle Scholar
- Quartara L, Maggi CA: The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activation. Neuropeptides 1997, 31: 537–563. 10.1016/S0143-4179(97)90001-9PubMedView ArticleGoogle Scholar
- Duggan AW: Release of neuropeptides in the spinal cord. Prog Brain Res 1995, 104: 197–223.PubMedView ArticleGoogle Scholar
- Urban L, Randic M: Slow excitatory transmission in rat dorsal horn: possible mediation by peptides. Brain Res 1984, 290: 336–341. 10.1016/0006-8993(84)90952-1PubMedView ArticleGoogle Scholar
- Mantyh PW, Rogers SD, Honore P, Allen BJ, Ghilardi JR, Li J, Daughters RS, Lappi DA, Wiley RG, Simone DA: Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science 1997, 278: 275–279. 10.1126/science.278.5336.275PubMedView ArticleGoogle Scholar
- Nichols ML, Allen BJ, Rogers SD, Ghilardi JR, Honore P, Luger NM, Finke MP, Li J, Lappi DA, Simone DA, Mantyh PW: Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science 1999, 286: 1558–1561. 10.1126/science.286.5444.1558PubMedView ArticleGoogle Scholar
- Cheing GL, Luk ML: Transcutaneous electrical nerve stimulation for neuropathic pain. J Hand Surg [Br] 2005, 30: 50–55. 10.1016/j.jhsb.2004.08.007View ArticleGoogle Scholar
- Warden MK, Young WS: Distribution of cells containing mRNAs encoding substance P and neurokinin B in the rat central nervous system. J Comp Neurol 1988, 272: 90–113. 10.1002/cne.902720107PubMedView ArticleGoogle Scholar
- Johansson O, Hokfelt T, Pernow B, Jeffcoate SL, White N, Steinbusch HW, Verhofstad AA, Emson PC, Spindel E: Immunohistochemical support for three putative transmitters in one neuron: coexistence of 5-hydroxytryptamine, substance P- and thyrotropin releasing hormone-like immunoreactivity in medullary neurons projecting to the spinal cord. Neuroscience 1981, 6: 1857–1881. 10.1016/0306-4522(81)90028-2PubMedView ArticleGoogle Scholar
- Li JL, Wang D, Kaneko T, Shigemoto R, Nomura S, Mizuno N: The relationship between neurokinin-1 receptor and substance P in the medullary dorsal horn: a light and electron microscopic immunohistochemical study in the rat. Neurosci Res 2000, 36: 327–334. 10.1016/S0168-0102(00)00095-XPubMedView ArticleGoogle Scholar
- Garcia M, Sakamoto K, Shigekawa M, Nakanishi S, Ito S: Multiple mechanisms of arachidonic acid release in Chinese hamster ovary cells transfected with cDNA of substance P receptor. Biochem Pharmacol 1994, 48: 1735–1741. 10.1016/0006-2952(94)90459-6PubMedView ArticleGoogle Scholar
- Cumberbatch MJ, Chizh BA, Headley PM: Modulation of excitatory amino acid responses by tachykinins and selective tachykinin receptor agonists in the rat spinal cord. Br J Pharmacol 1995, 115: 1005–1012.PubMed CentralPubMedView ArticleGoogle Scholar
- Trafton JA, Abbadie C, Basbaum AI: Differential contribution of substance P and neurokinin A to spinal cord neurokinin-1 receptor signaling in the rat. J Neurosci 2001, 21: 3656–3664.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.